I speak to Matt about his wonderful collection of old (retro?) computers but also all about the challenges of defining an ethical framework for algorithms, and what we can do to understand this tricky area.
New Jersey’s $85 billion fund stockpiles cash, eyes PE secondaries
An underweight position across private markets, predicated on a view that geopolitics and inflation mean interest rates are not coming down any time soon, has positioned the New Jersey Division of Investment with plenty of dry powder and a cash position four times the policy allocation. It is now readying for opportunities in private equity secondaries and with emerging managers. Chief investment officer Shoaib Khan spoke to Top1000funds.com.
Sort content by
Alpha alone does not pay pensions – total returns do
Pension fund members in retirement want the sustainability of pension payments. OPTrust chief investment officer James Davis told the Top1000Funds Fiduciary Investors Symposium that a total portfolio approach is the best way to do that, and has been on a journey towards delivering it for the past 10 years.
Long-term investors can help break VC’s short-term trap
The short-term investment focus of venture capital investors and the withdrawal of government funding are opening the door to asset owners as providers of patient, long-term capital to fill an investment void, the Top1000funds.com Fiduciary Investors Symposium has heard.
TPA is in the eye of the beholder
Total portfolio approach is not a method, it’s a mindset, according to University of Toronto finance Professor Redouane Elkamhi. Also a senior advisor to HOOPP, Elkamhi said he would summarise TPA in one sentence: "How to be prepared for different market conditions."
Federal threats undermine Massachusetts’ edge, warns state treasurer
Massachusetts treasurer Deborah Goldberg warned that the state’s key strengths – including its higher education institutions and progressive social policies – are being targeted by the federal administration. She urged support from investors as federal funding for innovations and research wanes.
What it means if ‘DNA is not destiny’
Geneticist David Sinclair says aging is a disease and it is preventable and treatable. He told the Fiduciary Investors Symposium that research demonstrates we can slow down or even reverse the aging process. It sounds like good news, but the consequences for society and the investment community are profound.
FIS Harvard 2025: Photo gallery
Explore our photo gallery from FIS Harvard, May 19-21, 2025.
Leave a Comment
You must be logged in to post a comment.
Login